Senator Green offered the following resolution:

            Senate Resolution No. 186.

            A resolution to memorialize the United States Congress to continue support for the 340B Drug Pricing Program.

            Whereas, Since its enactment in 1992, the 340B Drug Pricing Program has provided necessary support to Michigan hospitals delivering medical services to vulnerable populations. The program provides financial relief from high prescription costs to these safety-net hospitals; and

            Whereas, While the 340B program represents only 2 percent of approximately $375 billion in annual prescription drug purchases in the United States, it has critical benefits for patients and communities. The program has reaped an invaluable and life-saving return on its investment; and

            Whereas, The 340B Drug Program has become a target by critics in the pharmaceutical industry. Some have suggested that scaling back the program would save costs by reducing the number of eligible hospitals and the types of patients that can be served under the program; and

            Whereas, Michigan hospitals, patients, and communities depend on the 340B program. Any effort to reduce support or to scale back this program could considerably harm vulnerable patients in communities throughout this state. It is vital in the effort to help Michigan hospitals stretch scarce resources to improve access to care; now, therefore, be it

            Resolved by the Senate, That we memorialize the United States Congress to continue support for the 340B Drug Pricing Program; and be it further

            Resolved, That copies of this resolution be transmitted to the President of the United States Senate, the Speaker of the United States House of Representatives, and the members of the Michigan congressional delegation.